We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

NIH grant recipients receive additional funding to cover "indirect costs," such as building maintenance and administrative ...

To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

Paul Gigot interviews Journal columnist Holman Jenkins.